These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 9716032

  • 21. Higher efficiency of 131I-labeled anti-carcinoembryonic antigen-monoclonal antibody F(ab')2 as compared to intact antibodies in radioimmunotherapy of established human colon carcinoma grafted in nude mice.
    Buchegger F, Mach JP, Folli S, Delaloye B, Bischof-Delaloye A, Pèlegrin A.
    Recent Results Cancer Res; 1996; 141():19-35. PubMed ID: 8722418
    [No Abstract] [Full Text] [Related]

  • 22. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD, Sharkey RM, Haywood L, Natale AM, Wong GY, Siegel JA, Kennel SJ, Goldenberg DM.
    Cancer Res; 1992 Nov 01; 52(21):6036-44. PubMed ID: 1394228
    [Abstract] [Full Text] [Related]

  • 23. Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.
    Pedley RB, Boden JA, Boden R, Dale R, Begent RH.
    Br J Cancer; 1993 Jul 01; 68(1):69-73. PubMed ID: 8318423
    [Abstract] [Full Text] [Related]

  • 24. Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability.
    Folli S, Pèlegrin A, Chalandon Y, Yao X, Buchegger F, Lienard D, Lejeune F, Mach JP.
    Int J Cancer; 1993 Mar 12; 53(5):829-36. PubMed ID: 8449608
    [Abstract] [Full Text] [Related]

  • 25. Radioimmunotherapy for liver micrometastases in mice: pharmacokinetics, dose estimation, and long-term effect.
    Saga T, Sakahara H, Nakamoto Y, Sato N, Zhao S, Iida Y, Kuroki M, Endo K, Konishi J.
    Jpn J Cancer Res; 1999 Mar 12; 90(3):342-8. PubMed ID: 10359050
    [Abstract] [Full Text] [Related]

  • 26. Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin.
    Koppe MJ, Soede AC, Pels W, Oyen WJ, Goldenberg DM, Bleichrodt RP, Boerman OC.
    Int J Cancer; 2003 Oct 10; 106(6):965-72. PubMed ID: 12918078
    [Abstract] [Full Text] [Related]

  • 27. Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model.
    Marshall D, Pedley RB, Boden JA, Boden R, Begent RH.
    Br J Cancer; 1994 Mar 10; 69(3):502-7. PubMed ID: 8123481
    [Abstract] [Full Text] [Related]

  • 28. In vivo studies on the uptake of radiolabelled antibodies by colorectal and gastric carcinoma xenografts.
    Macdonald F, Crowson MC, Allum WH, Life P, Fielding JW.
    Cancer Immunol Immunother; 1986 Mar 10; 23(2):119-24. PubMed ID: 3779713
    [Abstract] [Full Text] [Related]

  • 29. Radioimmunotherapy of human colon cancer xenografts with 131I-labeled anti-CEA monoclonal antibody.
    Liu Z, Jin C, Yu Z, Zhang J, Liu Y, Zhao H, Jia B, Wang F.
    Bioconjug Chem; 2010 Feb 17; 21(2):314-8. PubMed ID: 20078028
    [Abstract] [Full Text] [Related]

  • 30. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
    Storto G, Buchegger F, Waibel R, Kuenzi G, Offord RE, Schubiger PA, Gillet M, Delaloye AB.
    Cancer Biother Radiopharm; 2001 Oct 17; 16(5):371-9. PubMed ID: 11776754
    [Abstract] [Full Text] [Related]

  • 31. Radioimmunotherapy of human colonic cancer xenografts with 90Y labeled monoclonal antibodies to carcinoembryonic antigen.
    Sharkey RM, Kaltovich FA, Shih LB, Fand I, Govelitz G, Goldenberg DM.
    Cancer Res; 1988 Jun 01; 48(11):3270-5. PubMed ID: 3365705
    [Abstract] [Full Text] [Related]

  • 32. Prediction of tumor response to experimental radioimmunotherapy with 90Y in nude mice.
    Dillehay LE, Mayer R, Zhang YG, Shao Y, Song SY, Mackensen DG, Williams JR.
    Int J Radiat Oncol Biol Phys; 1995 Sep 30; 33(2):417-27. PubMed ID: 7673029
    [Abstract] [Full Text] [Related]

  • 33. Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1).
    Siler K, Eggensperger D, Hand PH, Milenic DE, Miller LS, Houchens DP, Hinkle G, Schlom J.
    Biotechnol Ther; 1993 Sep 30; 4(3-4):163-81. PubMed ID: 8292968
    [Abstract] [Full Text] [Related]

  • 34. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
    Dorvillius M, Garambois V, Pourquier D, Gutowski M, Rouanet P, Mani JC, Pugnière M, Hynes NE, Pèlegrin A.
    Tumour Biol; 2002 Sep 30; 23(6):337-47. PubMed ID: 12677091
    [Abstract] [Full Text] [Related]

  • 35. Diverse characteristics of 111In labelled anti-CEA monoclonal antibodies for tumour immunoscintigraphy: radiolabelling, biodistribution and imaging studies in mice with human tumour xenografts.
    Pimm MV, Perkins AC, Baldwin RW.
    Eur J Nucl Med; 1987 Sep 30; 12(10):515-21. PubMed ID: 3569340
    [Abstract] [Full Text] [Related]

  • 36. Radioimmunotherapy with 153Sm-CEA monoclonal antibody in nude mice bearing human colon carcinoma: an experimental study.
    Li GP, Zhang H, Zhu CM.
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jan 30; 23(1):1-5. PubMed ID: 12527502
    [Abstract] [Full Text] [Related]

  • 37. Adjuvant 131I-anti-CEA-antibody radioimmunotherapy inhibits the development of experimental colonic carcinoma liver metastases.
    Mahteme H, Lövqvist A, Graf W, Lundqvist H, Carlsson J, Sundin A.
    Anticancer Res; 1998 Jan 30; 18(2A):843-8. PubMed ID: 9615730
    [Abstract] [Full Text] [Related]

  • 38. Influence of antibody protein dose on therapeutic efficacy of radioiodinated antibodies in nude mice bearing GW-39 human tumor.
    Boerman OC, Sharkey RM, Wong GY, Blumenthal RD, Aninipot RL, Goldenberg DM.
    Cancer Immunol Immunother; 1992 Jan 30; 35(2):127-34. PubMed ID: 1375872
    [Abstract] [Full Text] [Related]

  • 39. Radioimmunolocalization and quantification of liver metastases and subcutaneous tumours from a human colonic cancer xenografted in the nude rat.
    Sundin A.
    Acta Radiol Suppl; 1993 Jan 30; 382():1-29. PubMed ID: 8456581
    [Abstract] [Full Text] [Related]

  • 40. Variables influencing tumor dosimetry in radioimmunotherapy of CEA-expressing cancers with anti-CEA and antimucin monoclonal antibodies.
    Behr TM, Sharkey RM, Juweid ME, Dunn RM, Ying Z, Zhang CH, Siegel JA, Goldenberg DM.
    J Nucl Med; 1997 Mar 30; 38(3):409-18. PubMed ID: 9074529
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.